The antiviral drug remdesivir reduces the time to recovery in COVID-19 patients
These are the first results of a global clinical trial in which the Hospital Clinic and ISGlobal participate.
News from April 2020
Researchers create a low-cost ventilator for areas with limited means
Researchers from the Respiratory biophysics and bioengineering IDIBAPS research group, the Biophysics and Bioengineering Unit of the UB and the CIBERES...
Smoking increases complications when infected with COVID-19
SARS-CoV-2 is a virus that affects people with respiratory diseases such as asthma, Chronic Obstructive Pulmonary Disease (COPD) or pulmonary fibrosis more...
ISGlobal and Hospital Clínic launch two new Studies to fight COVID-19
The prophylactic and serological studies will be performed on healthcare workers at Hospital Clínic of Barcelona.